Table 2.
List of compounds used in this study.
| Compound name | ID |
|---|---|
| Quinic acid | 1 |
| Hesperetin-7-O-(rhamnoside, glucoside)-glucoside | 2 |
| Hesperetin (*) | 3 |
| Dimethoxycinnamoylhexoside | 4 |
| Ferulic acid (*) | 5 |
| 5-O-cafeoylquinic acid | 6 |
| Luteolin-3′,7-di-O-glucoside | 7 |
| Myricetin glucuronide | 8 |
| Methylmyricetin-O-glucuronide | 9 |
| Vicenin-2 | 10 |
| Myricetin rhamno-hexoside | 11 |
| Myricetin (*) | 12 |
| Quercetin 3-O-(2, 6-di-orhamnosyl-glucoside) | 13 |
| Luteolin 6,8-di-C-hexoside | 14 |
| Luteolin | 15 |
| Avicularin | 16 |
| Pinoquercetin | 17 |
| Quercetin | 18 |
| Quercetin-3-O-arabinoglucoside | 19 |
| Apigenin 6,8-di-C-glucoside (vicenin-3) | 20 |
| Apigenin (*) | 21 |
| Quercetin-O-rutinoside | 22 |
| Quercetin-3-glucuronide | 23 |
| Quercetin-3-galactoside-6′'-rhamnoside-3′''-rhamnoside | 24 |
| Dihydroxy-methoxyflavanone-O-rutinoside | 25 |
| 5,7-dihydroxy-4′-methoxyflavanone (*) | 26 |
| Kaempferol-3-O-glucoside | 27 |
| Kaempferol-3-O-glucuronide | 28 |
| Kaempferol (*) | 29 |
| Isorhamnetin-3-O-(6-O-rhamnosyl-galactoside) | 30 |
| Isorhamnetin (*) | 31 |
| Isorhamnetin-3-O-glucoside-6-O-rhamnoside | 32 |
| 2-(3,4-dihydroxyphenyl)-3,5,6-trihydroxychromen-4-one (*) | 33 |
| Sennoside | 34 |
| Baicalin | 35 |
| Hydroxyhein-O-rhamnoside–glucoside | 36 |
| Rhein (*) | 37 |
| Sagerinic acid | 38 |
| Caffeic acid trimer | 39 |
| (2S,3S,4S,5R,6S)-6-[2-(3,4- Dihydroxyphenyl)-5- hydroxy-4-oxochromen-7- yl]oxy-3,4,5- trihydroxyoxane-2- carboxylic acid | 40 |
| Lithospermic acid | 41 |
| Triterpene acid-O-hexoside | 42 |
| (Epi)gallocatechin (**) | 43 |
| (Epi)catechin dimer (**) | 44 |
| Benzenebutanoic acid, 4-methoxy-, methyl ester (***) | 45 |
| l-Leucine, N-isobutoxycarbonyl-N-methyl-, heptyl ester (***) | 46 |
| 7-Acetyl-6-ethyl-1,1,4,4-tetramethyltetralin (***) | 47 |
| Benzoic acid, 2-(ethylthio)-, ethyl ester (***) | 48 |
| Undecanoic acid, trimethylsilyl ester (***) | 49 |
| 1H-.beta.-Carboline-3-carboxylic acid, 1-isopropyl-2,3,4,9-tetrahydro-, methyl ester (***) | 50 |
| Isopeucenin (***) | 51 |
Note: (*) Because it is possible the hydrolysis of the glycoside part of several of those molecules (especially in the acidic gastric environment), we decided to include also the molecules free from the glyosidic portion of the molecule. (**) The original tentative identification was (Guevara et al., 2020): (Epi)gallocatechin-(epi)catechin dimer. Following the same logic both molecules were considered separately. (***) Molecules identified by GC–MS analysis.